GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Greater Cannabis Co Inc (OTCPK:GCAN) » Definitions » EV-to-EBITDA

Greater Cannabis Co (Greater Cannabis Co) EV-to-EBITDA : -4.91 (As of May. 21, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Greater Cannabis Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Greater Cannabis Co's enterprise value is $0.83 Mil. Greater Cannabis Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.17 Mil. Therefore, Greater Cannabis Co's EV-to-EBITDA for today is -4.91.

The historical rank and industry rank for Greater Cannabis Co's EV-to-EBITDA or its related term are showing as below:

GCAN' s EV-to-EBITDA Range Over the Past 10 Years
Min: -10.08   Med: 0.32   Max: 90.43
Current: -4.91

During the past 8 years, the highest EV-to-EBITDA of Greater Cannabis Co was 90.43. The lowest was -10.08. And the median was 0.32.

GCAN's EV-to-EBITDA is ranked worse than
100% of 710 companies
in the Drug Manufacturers industry
Industry Median: 14.875 vs GCAN: -4.91

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-21), Greater Cannabis Co's stock price is $0.0007. Greater Cannabis Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $0.000. Therefore, Greater Cannabis Co's PE Ratio for today is N/A.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Greater Cannabis Co EV-to-EBITDA Historical Data

The historical data trend for Greater Cannabis Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greater Cannabis Co EV-to-EBITDA Chart

Greater Cannabis Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial -1.61 9.90 -5.93 -2.77 -5.68

Greater Cannabis Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.37 -3.13 -5.30 -5.68 -

Competitive Comparison of Greater Cannabis Co's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Greater Cannabis Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Greater Cannabis Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Greater Cannabis Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Greater Cannabis Co's EV-to-EBITDA falls into.



Greater Cannabis Co EV-to-EBITDA Calculation

Greater Cannabis Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.834/-0.17
=-4.91

Greater Cannabis Co's current Enterprise Value is $0.83 Mil.
Greater Cannabis Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Greater Cannabis Co  (OTCPK:GCAN) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Greater Cannabis Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0007/0.000
=N/A

Greater Cannabis Co's share price for today is $0.0007.
Greater Cannabis Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Greater Cannabis Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Greater Cannabis Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Greater Cannabis Co (Greater Cannabis Co) Business Description

Traded in Other Exchanges
N/A
Address
15 Walker Avenue, Suite 101, Baltimore, MD, USA, 21208
Greater Cannabis Co Inc ia a biopharmaceutical company focused on the development and commercialization of innovative cannabinoid therapeutics. The firm focuses on cannabis-related investment and development opportunities through direct equity investments, joint ventures, licensing agreements, or acquisitions and also on commercializing its eluting transmucosal patch platform (ETP) technology. The company's operations are focused on its online store, GCC Superstore. The firm is involved in additional research and development of innovative cannabinoid-based therapeutics.
Executives
Jimmy Wayne Anderson 10 percent owner 501 1ST AVENUE NORTH, SUITE 901, ST. PETERSBURG FL 33701